S&P 500

5.302,44

1,06%

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

CRTX

Cortexyme (CRTX)

Cortexyme Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CRTX

1 2 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
26/05/2023	23h51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRTX	Cortexyme Inc
26/05/2023	23h50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRTX	Cortexyme Inc
25/05/2023	22h26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRTX	Cortexyme Inc
14/04/2023	22h13	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:CRTX	Cortexyme Inc
14/04/2023	22h07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:CRTX	Cortexyme Inc
05/04/2023	23h16	Edgar (US Regulatory)	Securities Registration (section 12(b)) (8-a12b)	NASDAQ:CRTX	Cortexyme Inc
31/03/2023	22h01	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CRTX	Cortexyme Inc
28/03/2023	23h05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRTX	Cortexyme Inc
15/03/2023	22h07	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:CRTX	Cortexyme Inc
03/03/2023	22h17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRTX	Cortexyme Inc
13/02/2023	23h29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CRTX	Cortexyme Inc
03/02/2023	00h38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRTX	Cortexyme Inc
03/02/2023	00h36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRTX	Cortexyme Inc
03/02/2023	00h33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRTX	Cortexyme Inc
03/02/2023	00h30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRTX	Cortexyme Inc
16/12/2022	22h04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRTX	Cortexyme Inc
07/12/2022	23h38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRTX	Cortexyme Inc
09/11/2022	22h26	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CRTX	Cortexyme Inc
08/09/2022	23h59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRTX	Cortexyme Inc
18/12/2009	19h45	PR Newswire (US)	Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010	NASDAQ:CRTX
20/11/2009	21h40	PR Newswire (US)	Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal	NASDAQ:CRTX
16/11/2009	14h00	PR Newswire (US)	Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference	NASDAQ:CRTX
13/11/2009	14h00	PR Newswire (US)	Cornerstone Therapeutics Appoints General Counsel	NASDAQ:CRTX
04/11/2009	13h00	PR Newswire (US)	Cornerstone Therapeutics Reports Third Quarter 2009 Financial Results	NASDAQ:CRTX
21/10/2009	14h00	PR Newswire (US)	Cornerstone Therapeutics to Host Third Quarter 2009 Conference Call	NASDAQ:CRTX
03/09/2009	14h01	PR Newswire (US)	Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)	NASDAQ:CRTX
03/09/2009	14h00	PR Newswire (US)	Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences	NASDAQ:CRTX
20/07/2009	14h00	PR Newswire (US)	Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal	NASDAQ:CRTX
16/07/2009	01h04	PR Newswire (US)	Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product	NASDAQ:CRTX
08/07/2009	22h15	PR Newswire (US)	Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect t	NASDAQ:CRTX